| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PARD6B | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | TXNL4A | CTRPv2 | pan-cancer | AAC | -0.22 | 0.01 |
| mRNA | DMXL2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | MS4A3 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | AC018755.18 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | GATAD2A | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | SLC6A16 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | TEAD2 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.01 |
| mRNA | RNASEL | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | HINT3 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
